Atlas Trials

BioLite, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch BioLite, Inc.

RecordFirmDate
A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients (NCT03833206)BioLite, Inc.2027-01-15
A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) (NCT02944955)BioLite, Inc.2027-01-01
Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer. (NCT02802423)BioLite, Inc.2027-01-01
PDC-1421 Treatment in Adult Patients With ADHD (NCT05202327)BioLite, Inc.2022-04-07
A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT02699086)BioLite, Inc.2019-12-01
A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder (NCT02395978)BioLite, Inc.2015-04-10
A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression (NCT01774045)BioLite, Inc.2012-11-01

Track BioLite, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.